KALOBA*SYR FL100ML 20MG/7.5ML

KALOBA syrup
Pelargonium root extract

What it is and what it is used for
KALOBA is a traditional herbal medicinal product containing Pelargonium root extract as its active ingredient.
KALOBA is indicated for the symptomatic treatment of the common cold in adults and children over 3 years of age.
The use of this traditional herbal medicinal product, for the indicated therapeutic uses, is based exclusively on long-standing experience.
Consult your doctor if you do not feel better or if you feel worse after 7 days.

What you need to know before taking the medicine
Do not take KALOBA:
- if you are allergic to Pelargonium or any of the other ingredients of this medicine (listed in section 6);
- if you have a tendency to bleed;
- if you are taking medicines that delay blood clotting;
- if you suffer from severe liver and kidney diseases (severe hepatic insufficiency and severe renal insufficiency).

Warnings and precautions
Consult your doctor or pharmacist before taking KALOBA.
Treatment with KALOBA should be stopped immediately and a doctor consulted if:
- liver problems occur (hepatotoxicity);
- increased respiratory rate (tachypnoea);
- presence of blood in the sputum (haemoptysis).

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The evaluation of side effects is based on frequency information:
Uncommon (may affect less than 1 in 100 but more than 1 in 1,000 people)
- Stomach ache, heartburn, nausea, vomiting, dysphagia, and diarrhoea.
Rare (may affect less than 1 in 1,000 but more than 1 in 10,000 people)
- Mild gum bleeding.
- Mild nosebleed.
- Hypersensitivity reaction (type-I reactions with rash, hives, itching of the skin and mucous membranes; type-II reactions with antibody formation).
Very rare (may affect less than 1 in 10,000 people)
- Severe hypersensitivity reactions with facial swelling, dyspnoea and a drop in blood pressure.
Not known (frequency cannot be estimated from the available data)
- Hepatotoxicity, hepatitis.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.